Accendra Health Inc. Common Stock (ACH)

About ACH

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure…

Sector

Health Care

Industry

Medical Specialities

Employees

6,500

Website

www.accendrahealth.com

Fundamentals

1-day range

$2.75$3.22

Market cap

$223.62M

P/E (trailing)

—

P/E (forward)

4.04

EPS (trailing)

$-14.06

Dividend yield

—

Beta

1.48

Avg. volume

776.0K

Ex-dividend date

December 14, 2021

Dividend pay date

December 31, 2021

Forecasts

5 analyst ratings

Accendra Health Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• ACH

  Accendra Health Inc. Common Stock

  $1.22

  ▲ 0.83%
  Market cap $223.62MP/E —
  $0.9337$5.69
• BDSX

  Biodesix Inc. Common Stock

  $26.81

  ▼ 5.86%
  Market cap $228.86MP/E —
  $5.26$31.31
• XGN

  Exagen Inc. Common Stock

  $7.38

  ▼ 1.86%
  Market cap $159.64MP/E —
  $2.59$12.23
• TLSI

  TriSalus Life Sciences Inc. Common Stock

  $4.85

  ▼ 1.62%
  Market cap $299.10MP/E —
  $2.2$7.95
• KEQU

  Kewaunee Scientific Corporation Common Stock

  $37.78

  ▼ 0.50%
  Market cap $108.73MP/E 10.89
  $33.27$59
• BNR

  Burning Rock Biotech Limited American Depositary Shares

  $10.19

  ▲ 1.90%
  Market cap $93.65MP/E —
  $6.79$41.72
• SERA

  Sera Prognostics Inc. Class A Common Stock

  $2.07

  ▲ 0.49%
  Market cap $78.32MP/E —
  $1.56$3.95

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Accendra Health (ACH) Price Target Decreased by 65.60% to 1.54
  Fintel · 8/28/2026
• Accendra Health Updates Capital Plans; Nets $45M From Non-Core Asset Sales And Sets CEO Succession Timeline For September
  benzinga · 8/17/2026
• Accendra Health Updates Capital Plans; Nets $45M From Non-Core Asset Sales And Sets CEO Succession Timeline For September
  Benzinga · 8/17/2026
• UBS Maintains Neutral on Accendra Health, Lowers Price Target to $1.5
  Benzinga · 8/13/2026
• Citigroup Downgrades Accendra Health (ACH)
  Fintel · 8/12/2026
• Citigroup Downgrades Accendra Health to Neutral, Lowers Price Target to $1.5
  Benzinga · 8/11/2026
• Here are the top movers in Monday's session.
  ChartMill · 8/10/2026
• Keep an eye on the top gainers and losers in Monday's session.
  ChartMill · 8/10/2026
• There are notable gap-ups and gap-downs in today's session.
  ChartMill · 8/10/2026

• Heath H. Galloway · May 15, 2026 · Tax Withholding

  966 @ $3.04
• Perry A. Bernocchi · May 15, 2026 · Tax Withholding

  7.9K @ $3.04
• Jonathan A. Leon · May 15, 2026 · Tax Withholding

  1.8K @ $3.04
• Edward A. Pesicka · May 15, 2026 · Tax Withholding

  17.7K @ $3.04
• Kenneth Gardner-Smith · May 14, 2026 · Grant

  31.2K
• Stephen W. Klemash · May 14, 2026 · Grant

  31.2K
• Bingham Gwendolyn M · May 14, 2026 · Grant

  31.2K
• Teresa L. Kline · May 14, 2026 · Grant

  31.2K
• Mark A. Beck · May 14, 2026 · Grant

  31.2K
• Heath H. Galloway · March 20, 2026 · Tax Withholding

  9.3K @ $2.03
• Perry A. Bernocchi · March 20, 2026 · Tax Withholding

  20.8K @ $2.03
• Jonathan A. Leon · March 20, 2026 · Tax Withholding

  11.3K @ $2.03
• Edward A. Pesicka · March 20, 2026 · Tax Withholding

  58.9K @ $2.03
• Heath H. Galloway · March 9, 2026 · Grant

  61.4K
• Perry A. Bernocchi · March 9, 2026 · Grant

  108.7K

Institutional Ownership

March 31, 2026

Total shares held

60.47M

Total value held

$135.63M

Institutional holders

137